— Know what they know.
Not Investment Advice

HYEX OTC

Healthy Extracts Inc.
1W: -12.5% 1M: -10.3% 3M: -51.2% YTD: -30.9% 1Y: -38.6% 3Y: -83.4% 5Y: -88.2%
$1.05
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 38 · $15.5M mcap · 1M float · 0.046% daily turnover · Short 68% of daily vol

Cash Flow Trends

Operating Cash Flow
$282K +167.8% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
$282K +167.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$5K +94.0% ▲
Net Change in Cash
$93K +300.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$3M-$2M-$983K-$2M-$841K
Depreciation & Amort.$9K$5K$878$2K-$139
Stock-Based Comp.$0$609K$402K$0$0
Change in Working Capital$138K$387K$233K$364K$313K
Other Non-Cash Items-$1M$694K$414K$2M$810K
Operating Cash Flow-$3M-$901K-$335K-$416K$282K
— Investing Activities —
Capital Expenditures-$8K-$96K-$8K$0$0
Acquisitions (Net)-$418K$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$116K-$96K$3K$0$0
Investing Cash Flow-$426K-$96K-$8K$0$0
— Financing Activities —
Net Debt Issuance$0$165K$251K$391K-$184K
Stock Repurchased$0$0-$11K-$90K-$5K
Dividends Paid$0$0$0$0$0
Other Financing-$4M$0-$11K$69K$0
Financing Cash Flow$4M$1M$240K$370K-$189K
Net Change in Cash-$74K$163K-$156K-$46K$93K
Cash End of Period$59K$222K$66K$19K$112K
Free Cash Flow-$3M-$997K-$343K-$416K$282K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms